• Neteera

  Participated · Series B · Apr 2023

  Neteera offers a passive, contactless patient monitoring platform that continuously captures vital signs and bio-data without cameras or device manipulation, protecting privacy. Its sensing technology is based on a maintenance-free sub-THz micro-radar on chip that eliminates the need for clothing removal or caregiver presence. The solution is FDA-cleared and targeted at strained healthcare settings and home health. In 2023 the company began selling to a large number of long-term care facilities in the U.S. and reports a significant pipeline of ordered products currently being deployed. Neteera plans to use newly raised funds to expedite production, meet demand for its platform, and recruit installation and deployment personnel. The company is led by CEO Isaac Litman and is based in Jerusalem, Israel. Neteera Technologies is a Jerusalem, Israel–based patient monitoring company led by CEO Isaac Litman. It offers an FDA-cleared continuous, contactless, passive vital-signs and bio-data monitoring solution for strained healthcare settings and home health. The sensing platform eliminates the need for device manipulation, removal of clothing, and caregiver presence. The technology is based on a safe, maintenance-free sub-THz micro-radar on-chip sensor and protects privacy by not using a camera. Neteera closed an approximately $13M Series B and intends to use the funds to accelerate sales, production and deployment of its contactless solution and to further develop features for its proprietary medical sensing platform. The company has also entered a strategic partnership with Omega Healthcare Investors to offer its technology to Omega’s healthcare operating partners.

No current team members are available.